Coinbase to begin 24/7 trading for DOGE, ADA, and SHIB futures on December 5. U.S. perpetual-style futures for DOGE, ADA, and SHIB launch December 12. Futures contracts will be accessible to both retail and institutional traders. Grayscale’s DOGE ETF set to list on NYSE Arca on November 24. Coinbase Markets has announced it will launch [...] The post Shiba Inu, Dogecoin And Cardano Included In Coinbase 24/7 Futures Launch appeared first on CoinCentral.Coinbase to begin 24/7 trading for DOGE, ADA, and SHIB futures on December 5. U.S. perpetual-style futures for DOGE, ADA, and SHIB launch December 12. Futures contracts will be accessible to both retail and institutional traders. Grayscale’s DOGE ETF set to list on NYSE Arca on November 24. Coinbase Markets has announced it will launch [...] The post Shiba Inu, Dogecoin And Cardano Included In Coinbase 24/7 Futures Launch appeared first on CoinCentral.

Shiba Inu, Dogecoin And Cardano Included In Coinbase 24/7 Futures Launch

  • Coinbase to begin 24/7 trading for DOGE, ADA, and SHIB futures on December 5.
  • U.S. perpetual-style futures for DOGE, ADA, and SHIB launch December 12.
  • Futures contracts will be accessible to both retail and institutional traders.
  • Grayscale’s DOGE ETF set to list on NYSE Arca on November 24.

Coinbase Markets has announced it will launch round-the-clock trading for a range of altcoin futures. The initiative includes Dogecoin (DOGE), Cardano (ADA), and Shiba Inu (SHIB), with both retail and institutional traders gaining access. The expansion begins December 5 and marks a continued effort by Coinbase to increase access to regulated crypto derivatives.

The exchange will also introduce perpetual-style futures for these tokens, structured for U.S. regulatory compliance. This development follows earlier rollouts of similar products for Bitcoin and Ethereum.

24/7 Futures Trading to Begin December 5

Starting December 5, Coinbase Markets will offer continuous trading of monthly futures contracts for 11 altcoins. These include Avalanche (AVAX), Bitcoin Cash (BCH), Cardano (ADA), Chainlink (LINK), Dogecoin (DOGE), Hedera (HBAR), Litecoin (LTC), Polkadot (DOT), Shiba Inu (SHIB), Stellar (XLM), and SUI.

This is an expansion of Coinbase Derivatives’ 24/7 offerings, which already cover Bitcoin, Ethereum, Solana, and XRP. Both institutional and retail investors will be able to access these new markets at all times.

Coinbase stated on X, “Our 24/7 trading model meets growing demand for continuous access across global markets.”

U.S. Perpetual-Style Futures Launching December 12

Coinbase will introduce a new class of perpetual-style futures for the same list of altcoins, including DOGE, ADA, and SHIB. These contracts will go live on December 12 and are designed for U.S. markets.

Unlike offshore perpetual swaps that have no expiry, Coinbase’s contracts will settle on a five-year timeline. They also use funding rates to keep prices close to spot values.

Coinbase noted that this model ensures regulatory alignment while reflecting the structure of traditional perpetual swaps. These contracts will operate under a compliant framework recognized by U.S. regulators.

DOGE, ADA, SHIB in Focus as Institutional Interest Rises

The launch comes amid a surge in institutional interest in tokens like Dogecoin, Cardano, and Shiba Inu. On November 24, NYSE Arca will list Grayscale’s DOGE ETF, which was recently certified. Grayscale has also filed for a Cardano ETF, pending approval by the SEC.

Asset manager T. Rowe Price has filed to launch a crypto-index ETF that will include SHIB. These moves indicate growing demand for investment vehicles tied to these altcoins in traditional markets.

The availability of perpetual-style futures and 24/7 trading may further support wider access and usage of these tokens among institutions and retail users.

Coinbase Continues to Expand Regulated Derivatives Access

Coinbase has positioned itself as the first major U.S. exchange to offer long-dated crypto futures under full regulatory compliance. The exchange previously launched 24/7 BTC and ETH futures in May and long-dated futures in July.

Most altcoin futures trading volume is still found on offshore platforms like Binance and Bybit. However, Coinbase’s push into regulated offerings may redirect some of this volume back to U.S.-based platforms.

The upcoming futures offerings are part of a broader strategy to create a more secure and compliant crypto derivatives market in the United States.

The post Shiba Inu, Dogecoin And Cardano Included In Coinbase 24/7 Futures Launch appeared first on CoinCentral.

Market Opportunity
BitShiba Logo
BitShiba Price(SHIBA)
$0.0000000004209
$0.0000000004209$0.0000000004209
-0.47%
USD
BitShiba (SHIBA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26